— Published date: 6/3/2026
Value Proposition: Using CLCA1 VWA to specifically potentiate TMEM16A to enhance mucociliary transport in cystic fibrosis and other mucus obstructive diseases.
Technology Description
Researchers at Washington University in St. Louis have developed a potentiator, CLCA1 …
— Published date: 11/11/2025
Value Proposition: Tissue processing and rapid imaging method for improving tissue clearing and visualization.
Technology Description
Researchers at Washington University in St. Louis have developed a new refractive index matching solution containing iohexol, sucrose,…
— Published date: 9/18/2025
Value Proposition: Software that can be used to distinguish between live and dead cells while allowing for the resorting of living cells.
Technology Description
Researchers at Washington University in St. Louis have developed a software suite that enables single-cell an…
— Published date: 9/18/2025
Value Proposition: Single chain RANK ligand that can selectively inhibit pathological bone loss.
Technology Description
Researchers at Washington University in St. Louis have developed a genetically engineered mutant RANKL protein that prevents bone loss by selective…
— Published Date: 8/5/2025
Value Proposition: Disease severity scoring system that can predict the progression of Wolfram syndrome.
Technology Description
Researchers at Washington University in St. Louis have developed a genotype-based severity scoring system to predict the onset of cardinal sym…
| Name | # Summaries | Author | Action |
|---|---|---|---|
| 15 | |||
| 13 | |||
| 1 | |||
| 15 | |||
| 26 | |||
| 14 | |||
| 14 |
Creating...
